Vyome Holdings (HIND) Asset Utilization Ratio (2016 - 2026)
Vyome Holdings (HIND) posted quarterly Asset Utilization Ratio of 0.16 for Q1 2026, down 90.14% year-over-year from 1.64 in Q1 2025, and down 27.79% quarter-over-quarter from 0.22 in Q4 2025.
Vyome Holdings (HIND) Asset Utilization Ratio (2016 - 2026) Analysis & Trends
Vyome Holdings' Asset Utilization Ratio history runs 11 years deep, the most recent figure standing at 0.16 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 90.14% year-over-year to 0.16; the TTM figure through Mar 2026 stood at 0.16 (down 90.14% YoY), while the FY2025 annual figure was 0.08, up 90.22% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.16, down from 0.22 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 3.05 in Q4 2024, with the low at 0.16 in Q1 2026.
- The 5-year median for Asset Utilization Ratio is 0.74 (2023), against an average of 0.81.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio surged 309.68% in 2023, then sank 92.68% in 2025.
- Vyome Holdings' Asset Utilization Ratio stood at 0.6 in 2022, then jumped by 57.11% to 0.94 in 2023, then surged by 224.82% to 3.05 in 2024, then tumbled by 92.68% to 0.22 in 2025, then retreated by 27.79% to 0.16 in 2026.
- Business Quant data shows HIND's Asset Utilization Ratio at 0.16 in Q1 2026, 0.22 in Q4 2025, and 0.19 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - | 0.13 |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.16 |
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | 0.19 |
| Jun 30, 2025 | 0.30 |
| Mar 31, 2025 | 1.64 |
| Dec 31, 2024 | 3.05 |
| Sep 30, 2024 | 1.56 |
| Jun 30, 2024 | 1.10 |
| Mar 31, 2024 | 0.88 |
| Dec 31, 2023 | 0.94 |
| Sep 30, 2023 | 1.00 |
| Jun 30, 2023 | 0.74 |
| Mar 31, 2023 | 0.81 |
| Dec 31, 2022 | 0.60 |
| Sep 30, 2022 | 0.24 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | 0.20 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.13 |